Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CyberMDX is a healthcare-focused cybersecurity company that provides visibility and threat prevention for medical devices and clinical networks. The company's platform utilizes a Device-Centric Cyber Security (DCCS) approach to identify, categorize, and protect the Internet of Medical Things (IoMT) within hospital environments. By providing real-time risk assessment and automated policy enforcement, CyberMDX helps healthcare delivery organizations ensure patient safety and data privacy. The solution integrates with existing network infrastructure to provide continuous monitoring and vulnerability management. In 2022, the company was acquired by Forescout Technologies to enhance their unified device visibility and control capabilities across the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CyberMDX.